If the nature of the second hit confers tumor cell identity to ETV6-RUNX1+ leukemia, we hypothesized that ETV6-RUNX1+ B-ALLs triggered by the loss of either Pax5 or Kdm5c should differ from one another. This evidence concerns the gene PAX5 and leukemia.